by Immunecyte | Mar 8, 2021 | Latst News
IRVINE, Calif., March 08, 2021 – HealthBanks Biotech (USA), Inc. (“HealthBanks” or the “Company”), a premium cell banking network, today announced that through its subsidiary, ImmuneCyte Inc. (“ImmuneCyte”), the Company has executed an acquisition agreement with...
by Immunecyte | Sep 3, 2020 | Latst News
RANCHO CORDOVA, Calif., Sept 2, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, along with its joint venture, ImmuneCyte, Inc. today announced plans to roll...
by Immunecyte | Apr 23, 2020 | Latst News
RANCHO CORDOVA, Calif., April 24, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that it was featured on multiple new outlets, including a Fox40...
by Immunecyte | Apr 16, 2020 | Latst News
COVID-19 Test Ready For Distribution — Irvine, Calif., April 16, 2020 — ImmuneCyte, announced today that on Wednesday April 15th, ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a major shareholder of ImmuneCyte, a market leader in automated cell processing...
by Immunecyte | Apr 13, 2020 | Latst News
IRVINE, Calif., April 13, 2020 – ImmuneCyte Life Sciences, Inc., announced today that the Company has completed the acquisition of worldwide intellectual property for developing fully human antibody therapeutics for COVID-19. The acquired intellectual property...
by Immunecyte | Apr 3, 2020 | Latst News
RANCHO CORDOVA, Calif., April 3, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that it was featured on a CBS 13 news segment titled, “Different...
Recent Comments